Latest Articles
Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All - Polity
Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All Polity
Published: Jan. 21, 2025, 7:36 a.m.
Causal analysis of dietary preferences and the risk of endometriosis using large-scale population data - Nature.com
Causal analysis of dietary preferences and the risk of endometriosis using large-scale population data Nature.com
Published: Jan. 21, 2025, 6:16 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning - Frontiers
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning Frontiers
Published: Jan. 21, 2025, 4:35 a.m.
Estate agent who was diagnosed with endometriosis wins £31k - MSN
Estate agent who was diagnosed with endometriosis wins £31k MSN
Published: Jan. 21, 2025, 3:51 a.m.
The high cost of neglecting women’s health - asianews.network
The high cost of neglecting women’s health asianews.network
Published: Jan. 21, 2025, 2:27 a.m.
Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis - BMC Public Health
Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis BMC Public Health
Published: Jan. 21, 2025, 1:41 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire
Published: Jan. 21, 2025, 12:38 a.m.
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive
Published: Jan. 20, 2025, 9:34 p.m.
5 actions to boost women's health and the global economy - World Economic Forum
5 actions to boost women's health and the global economy World Economic Forum
Published: Jan. 20, 2025, 8:05 p.m.
Link copied to clipboard!